Dr. Goldner studies the factors that can lead to complications after liver surgeries in children. Specifically, he investigates why some children end up being readmitted to the hospital shortly after their surgery. His research spans several aspects, including identifying which patients are at greater risk for complications, such as infections, and evaluating how these issues affect overall recovery and healthcare costs. By analyzing data from thousands of pediatric surgeries, he aims to improve treatment protocols and enhance patient care.
Key findings
In his analysis of 438 pediatric patients, he found a 14.6% rate of unplanned readmission within 30 days after liver surgery.
Patients with organ-space surgical site infections had their odds of readmission tripled compared to those without such infections.
Children with active cancer, gastrointestinal diseases, or who required nutritional support were found to be at a higher risk for readmission.
Frequently asked questions
Does Dr. Goldner study liver surgery in children?
Yes, he specializes in pediatric liver surgery and its outcomes.
What factors cause children to be readmitted after liver surgery?
His research indicates that surgical site infections, active cancer, gastrointestinal issues, and nutritional support needs increase the likelihood of readmission.
How can Dr. Goldner's research help patients?
By identifying risk factors for complications, his work aims to improve surgical care and reduce hospital readmissions, ultimately enhancing patient safety.
Publications in plain English
Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN-γ-directed therapies.
2025
The Journal of allergy and clinical immunology
Nguyen TH, Satwani P, Kumar D, Kapoor U, Malik S +11 more
Plain English This study focused on understanding a type of severe liver inflammation in children called indeterminate severe hepatitis (iSH) and how it compares to a related condition known as hemophagocytic lymphohistiocytosis (HLH). Researchers found that patients with iSH had signs of heightened immune system activity similar to those with HLH, and this activation was linked to the risk of worsening liver failure. Specifically, they discovered that the level of T-cell activation could predict if a patient with iSH might develop more severe liver problems, and using a certain antibody treatment helped improve liver function in some cases.
Who this helps: This research benefits doctors and patients with indeterminate severe hepatitis by guiding treatment decisions.
Bentonite-modified glassy carbon electrode for the voltammetric determination of caffeine in beverages.
2025
Food chemistry
Soares NO, Goldner DMB, Masini JC
Plain English This study developed a special type of electrode that improves the detection of caffeine in drinks. The new electrode was able to accurately measure caffeine levels in a range from 0.25 to 4.0 micromolar, with limits that were five times lower than traditional methods. This is significant because it provides a fast and cost-effective way to check caffeine levels in various beverages with less interference from other substances.
Who this helps: This helps beverage manufacturers, researchers, and consumers who want accurate caffeine information in drinks.
The evolving landscape of pediatric hepatology: key updates and future directions.
2025
Current opinion in pediatrics
Lu P, Ovchinsky N, Goldner D
Plain English This paper discusses recent advancements in pediatric liver health, particularly focusing on new ways to diagnose and treat liver diseases in children. It highlights that nonalcoholic fatty liver disease is now better understood as a metabolic issue, improving diagnosis. New treatments, such as drugs that help manage certain liver conditions, have shown to enhance children's growth and quality of life significantly.
Who this helps: This benefits children with liver diseases and their families.
Fractionated plasma N-glycan profiling of novel cohort of ATP6AP1-CDG subjects identifies phenotypic association.
2023
Journal of inherited metabolic disease
Alharbi H, Daniel EJP, Thies J, Chang I, Goldner DL +19 more
Plain English This study looked at 11 patients with ATP6AP1-CDG, a genetic disorder that can affect the liver and immune system. Researchers found that patients showed a wide range of symptoms, including liver cancer and unique immune issues, and they highlighted that certain changes in blood proteins, called N-glycans, can help doctors diagnose and monitor the disease. Specifically, after liver transplants, some patients showed improvements in their blood protein markers, while others with immune issues had different patterns in their blood.
Who this helps: This research benefits patients with ATP6AP1-CDG and their doctors by providing better tools for diagnosis and management.
Reducing Treatment Burden Among People With Chronic Conditions Using Machine Learning: Viewpoint.
2022
JMIR biomedical engineering
Nagra H, Goel A, Goldner D
Plain English This paper studies how using machine learning and digital health technologies can help reduce the stress and effort involved in managing chronic conditions. The researchers found that current eHealth models don't fully address these issues, and proposed a new machine learning approach that could make a significant difference in supporting patients. This is important because it can lower the risk of burnout for those managing long-term health challenges.
Who this helps: This helps patients with chronic conditions.
Practical and technical aspects for the 3D scanning of lithic artefacts using micro-computed tomography techniques and laser light scanners for subsequent geometric morphometric analysis. Introducing the StyroStone protocol.
2022
PloS one
Göldner D, Karakostis FA, Falcucci A
Plain English Researchers developed a new method called StyroStone to effectively 3D scan small stone tools found in archaeology, like tiny blades and flakes, which are usually difficult to digitize accurately. Their technique uses advanced imaging technology to scan hundreds of these artifacts at once, making the process faster and more efficient. The study confirmed this method's accuracy by comparing scans of small artifacts produced with different equipment. This advancement helps improve the preservation and analysis of our prehistoric heritage.
Who this helps: This benefits archaeologists and researchers studying ancient human tools and cultures.
Effects of a Novel Blood Glucose Forecasting Feature on Glycemic Management and Logging in Adults With Type 2 Diabetes Using One Drop: Retrospective Cohort Study.
2022
JMIR diabetes
Imrisek SD, Lee M, Goldner D, Nagra H, Lavaysse LM +3 more
Plain English This study looked at how a new blood glucose forecasting feature in the One Drop app affected adults with type 2 diabetes. Researchers found that users who received these forecasts logged their blood sugar more often and had lower average blood glucose levels—about 20 mg/dL lower—and 15% more readings in the healthy range compared to those who did not receive forecasts. This matters because better blood sugar control can reduce the risk of complications for people with diabetes.
Who this helps: This helps patients with type 2 diabetes improve their health.
One Drop Improves Productivity for Workers With Type 2 Diabetes: One Drop for Workers With Type 2 Diabetes.
2022
Journal of occupational and environmental medicine
Lavaysse LM, Imrisek SD, Lee M, Osborn CY, Hirsch A +5 more
Plain English This study looked at how a mobile health program called One Drop affects productivity for workers with type 2 diabetes. Researchers found that after three months, the 125 employees using One Drop showed significant improvements in their work performance, reducing time lost from illness and increasing their overall productivity. This matters because it not only helps employees manage their diabetes better but also provides financial benefits to employers through increased work output.
Who this helps: This helps employees with type 2 diabetes and their employers.
Bone Fractures in Children With Cholestatic Liver Disease May Mimic Those Seen in Child Abuse.
2021
Pediatric emergency care
Goldner D, Vittorio J, Barrios DM, McGuire J, Brodlie S +3 more
Plain English This study looked at 15 children with cholestatic liver disease (CLD) who experienced bone fractures due to weakened bones, a condition that's common in these patients. It found that 5 of these children were reported for possible child abuse because their fractures resembled those typically caused by injury, not medical conditions. This matters because it highlights that doctors need to be aware that children with CLD can have broken bones from their illness, not just from abuse.
Who this helps: Patients with CLD and their families.
Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks.
2021
Clinical transplantation
Chen J, Salerno D, Breslin N, Chowdhury T, Lobritto S +3 more
Plain English Researchers studied the effects of using ketorolac, a pain-relieving medication, alongside tacrolimus, a common drug given after liver transplants in children. They found that 25.8% of children receiving ketorolac experienced acute kidney injury, compared to 29.2% of those who did not, indicating safety in using both drugs together. Additionally, kids on ketorolac needed less opioid medication for pain and had shorter hospital stays.
Who this helps: This benefits pediatric liver transplant patients and their healthcare teams.
Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.
2021
BMC infectious diseases
Jing R, Vunnam RR, Schnaubelt E, Vokoun C, Cushman-Vokoun A +2 more
Plain English This study looked at a 60-year-old man with kidney failure undergoing hemodialysis who got sick with both COVID-19 and influenza A at the same time. He showed flu-like symptoms, including a fever that peaked at 38.6°C, and was found to have high levels of a specific protein that usually indicates infection. The research highlights the importance of testing for COVID-19 in patients who might have other viral infections, particularly since those with kidney issues are at higher risk of severe illness.
Who this helps: This helps patients with kidney disease and healthcare providers treating them.
Risk Factors for 30-Day Unplanned Readmission After Hepatectomy: Analysis of 438 Pediatric Patients from the ACS-NSQIP-P Database.
2021
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Kang E, Shin JI, Griesemer AD, Lobritto S, Goldner D +3 more
Plain English Liver removal surgery in children carries real risks, but population-level data on complications are limited. Using a national pediatric surgical database, researchers identified which factors—including wound class and operative time—predict unplanned readmission within 30 days of hepatectomy. These benchmarks help hospitals identify high-risk patients and plan better follow-up care.
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
2020
Gastroenterology
Goldner D, Lavine JE
Plain English This study looked at nonalcoholic fatty liver disease (NAFLD) in children, which is becoming more common as obesity rates rise. Researchers found that children are more affected by both genetic and environmental influences when it comes to this disease, and they may face lifelong health issues because of it. New tests and treatments are urgently needed to help address the growing numbers of affected kids and prevent serious health problems in the future.
Who this helps: This helps children at risk for NAFLD, their families, and healthcare providers.
Role of Budesonide for the Treatment of Rejection in Pediatric Liver Transplantation.
2020
Journal of pediatric gastroenterology and nutrition
Chen J, Ferreira J, Martinez M, Lobritto S, Goldner D +1 more
Plain English This study looked at the use of budesonide, an oral corticosteroid, to treat acute cellular rejection in children who received liver transplants. They found that 29 children showed a significant decrease in liver enzyme levels (ALT) after starting budesonide, with results improving at 1, 3, and 6 months post-treatment. This matters because it suggests that budesonide could be a safer and effective alternative to traditional steroids, which often have more side effects.
Who this helps: This helps pediatric liver transplant patients by providing a potentially safer treatment option for managing rejection.
A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation.
2020
Pediatric transplantation
Heinz N, Griesemer A, Kinney J, Vittorio J, Lagana SM +5 more
Plain English This study focuses on a 6-month-old baby who received a liver transplant and was diagnosed with COVID-19 just four days later. After initially recovering well, her liver enzyme levels rose significantly, indicating liver irritation, but her condition improved after treatment with hydroxychloroquine and other medications. This finding highlights the potential complications that COVID-19 can cause in young liver transplant patients and the importance of monitoring and adjusting their treatment.
Who this helps: This helps pediatric patients who have undergone liver transplants and their healthcare providers.
MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults.
2014
Pediatric radiology
Shenoy-Bhangle A, Nimkin K, Goldner D, Bradley WF, Israel EJ +1 more
Plain English This study looked at how MRI can help predict how well children and young adults with Crohn's disease will respond to treatment for perianal fistulas. Researchers found that if the longest fistula is less than 2.5 cm, patients are more likely to respond to treatment, while those with an aggregate fistula length of 2.5 cm or more are more likely to see their disease worsen. Understanding these MRI features can help doctors make better treatment decisions for young patients with Crohn's disease.
Who this helps: This benefits patients with Crohn's disease and their healthcare providers.
Posttraumatic appendicitis: further extending the extended Focused Assessment with Sonography in Trauma examination.
2009
The American journal of emergency medicine
Derr C, Goldner DE
Plain English This study looked at a case of a 41-year-old man who developed appendicitis after a hard landing while cliff diving. Despite initially showing no serious issues during an ultrasound in the emergency room, a more focused scan later revealed that his appendix was inflamed and required treatment. This finding highlights that ultrasound can be a useful tool for identifying appendicitis in patients who have experienced abdominal trauma, potentially speeding up diagnosis and treatment.
Who this helps: This helps emergency room doctors and cruise ship medical staff in diagnosing appendicitis in trauma patients.
Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule.
2005
Nature medicine
Gaston SM, Soares MA, Siddiqui MM, Vu D, Lee JM +11 more
Plain English In this study, researchers developed new techniques called 'tissue printing' and 'print-phoresis' to analyze human prostate tissue samples. They found that these methods can help identify tumor markers related to cancer spreading beyond the prostate capsule, which is important for surgical outcomes; specifically, they can create detailed maps that show where tumors invade. This matters because it can improve how doctors diagnose and treat prostate cancer, potentially leading to better surgery results and less cancer recurrence.
Who this helps: This benefits patients with prostate cancer and their doctors.
Plain English This study tested how well a new abdominal exercise machine called the AbVice worked compared to other popular devices like the AbRoller and AbRocker. It involved 24 college students performing abdominal crunches, where the AbVice showed much higher muscle activation, measuring 1,165.21 mV, compared to 242.92 mV for the AbRocker and 753.29 mV for the AbRoller. This matters because stronger abdominal muscles can improve core strength and stability, which is important for overall health and fitness.
Who this helps: This benefits fitness enthusiasts looking for effective ways to strengthen their abdominal muscles.
Comparison of efficacy and safety of atorvastatin (10mg) with simvastatin (10mg) at six weeks. ASSET Investigators.
2001
The American journal of cardiology
Insull W, Kafonek S, Goldner D, Zieve F
Plain English This study looked at how well two cholesterol-lowering medications, atorvastatin and simvastatin, worked over six weeks in over 1,400 patients with high triglyceride levels. Atorvastatin lowered bad cholesterol (LDL) by 37.2% compared to 29.6% for simvastatin, and it also helped a higher percentage of patients reach their cholesterol goals (55.6% vs. 38.4%). This is important because better cholesterol control can reduce the risk of heart disease.
Who this helps: Patients with high cholesterol levels, especially those with mixed dyslipidemia.
Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease.
1987
The American journal of cardiology
Sinoway L, Minotti J, Musch T, Goldner D, Davis D +2 more
Plain English This study looked at how diuretic therapy, which helps remove excess fluid, affects blood flow in patients with severe heart failure caused by heart artery disease. After 24 hours of treatment, blood flow improved significantly, increasing from about 20 to 26 ml per minute in a group of 9 hospitalized patients, indicating better blood vessel response. However, there was no further improvement after losing more weight, suggesting that other factors might also limit blood flow in these patients.
Who this helps: This research benefits patients with congestive heart failure and their doctors by highlighting the importance of managing fluid levels to improve blood circulation.
Dana Goldner Mercedes Martinez Steven Lobritto Jennifer Vittorio Harpreet Nagra Dan Goldner Dana L Goldner Lindsey M Lavaysse Steven D Imrisek Matthew Lee
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.